News &
Notifications
All Categories
March 7, 2019 | Co-investor invests further 20 million euros in TTTech" width="172" height="174" data-ratio="1.0116279069767"/>March 7, 2019 | Co-investor invests further 20 million euros in TTTech
The Co-Investor Group, a mid cap private equity investor based in Zürich and Frankfurt am Main, has increased its investment in Vienna-based TTTech Computertechnik AG (hereinafter referred to as TTTech Group) by a further 20 million euros.
March 6, 2019 | SMT Scharf AG reports strong revenue growth in the 2018 fiscal year" width="172" height="174" data-ratio="1.0116279069767"/>March 6, 2019 | SMT Scharf AG reports strong revenue growth in the 2018 fiscal year
Corporate news
to the archive
SMT Scharf AG reports strong revenue growth in the 2018 fiscal year
Hamm, March 6, 2019 - SMT Scharf ...
March 5, 2019 | Co-Investor and Catagonia agree close partnership" width="0" height="0" data-ratio="1"/>March 5, 2019 | Co-Investor and Catagonia agree close partnership
Corporate news
to the archive
Co-Investor and Catagonia agree close partnership
Dr. Ralph Eric Kunz to become new partner ...
March 4, 2019 | Dermapharm Holding SE acquires stake in cannabis producer for pharmaceutical applications" width="0" height="0" data-ratio="1"/>March 4, 2019 | Dermapharm Holding SE acquires stake in cannabis producer for pharmaceutical applications
Corporate news
to the archive
Dermapharm Holding SE acquires stake in cannabis producer for pharmaceutical applications
Grünwald, ...
February 22, 2019 | KROMI publishes H1 2018/2019 report" width="172" height="174" data-ratio="1.0116279069767"/>February 22, 2019 | KROMI publishes H1 2018/2019 report
Corporate news
to the archive
KROMI publishes H1 2018/2019 report
Hamburg, February 22, 2019 – KROMI Logistik AG, a ...
February 21, 2019 | Dermapharm continues to drive development of new products" width="0" height="0" data-ratio="1"/>February 21, 2019 | Dermapharm continues to drive development of new products
Grünwald, February 21, 2019 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany, has launched the products Azedil® and Momekort® in Germany just in time for the hay fever season. In addition, the patented medical product bite away® from the 2018 Hyperthermia range has performed well in all sales channels.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
